Table 5.
COX proportional hazard regression model test (enter method) for DFS
| B | SE | Wald | p-Value | Exp(B) | 95% CI for Exp(B) | ||
| Lower | Upper | ||||||
| Age | 0.052 | 0.027 | 3.691 | 0.055 | 1.053 | 0.999 | 1.110 |
| Tumour size | 0.042 | 0.025 | 2.863 | 0.091 | 1.042 | 0.993 | 1.094 |
| Number of positive LNs | 0.287 | 0.109 | 6.876 | 0.009 | 1.332 | 1.075 | 1.651 |
| Histological grade | −0.736 | 0.711 | 1.069 | 0.301 | 0.479 | 0.119 | 1.932 |
| LVI | 1.198 | 0.724 | 2.738 | 0.098 | 3.313 | 0.802 | 13.693 |
| HR | −0.590 | 0.508 | 1.344 | 0.246 | 0.555 | 0.205 | 1.502 |
| HER2 | 0.702 | 0.389 | 3.265 | 0.071 | 2.018 | 0.942 | 4.323 |
| Ki67 | −0.406 | 2.636 | 0.024 | 0.878 | 0.666 | 0.004 | 116.750 |
| Chemotherapy | −0.952 | 0.686 | 1.925 | 0.165 | 0.386 | 0.101 | 1.481 |
DFS, disease-free survival; HER2, human epidermal growth factor 2; HR, hormone receptor; LN, lymph node; LVI, lymphovascualar invasion.